Delivery Order SPE2DR25D2101-SPE2DR26F47PC
Award Date 1/21/26
Potential Completion Date 1/22/26
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $23,087.13 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on January 21, 2026, with completion expected by January 22, 2026. This contract was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the parent organization Cencora,...
- The Defense Logistics Agency awarded a delivery order valued at $31,740.85 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets (30-count packages). This competitively awarded, firm fixed-price delivery order was issued on January 9, 2026, with an ultimate completion date of January 12, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside contract, this award reflects open competition in the...
- The Defense Logistics Agency awarded a delivery order valued at $8,201.71 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) on January 12, 2026, with completion scheduled for January 13, 2026. This is a firm fixed-price, non-set-aside contract with performance at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal healthcare systems to manage nausea and vomiting, particularly in acute care...
- The Defense Logistics Agency awarded a $1,151.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply) on January 13, 2026, with an ultimate completion date of January 14, 2026. This contract was awarded without a set-aside designation on a competitive basis and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency awarded a delivery order valued at $1,663.17 to Amerisourcebergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count package). The award, issued on January 8, 2026, is structured as a firm fixed-price contract with an ultimate completion date of January 9, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This contract was not designated as a set-aside and was competitively awarded, reflecting...
- The Defense Logistics Agency awarded a $15,452.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Ondansetron ODT 8 mg tablets (30-count units), with an ultimate completion date of January 8, 2026. This non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,437.70 to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of April 25, 2025. The award was made through open competition without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $2,903.79 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count) on January 16, 2026, with a completion date of January 20, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The order represents a task issued under AmerisourceBergen's parent company Cencora, Inc.'s larger...
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 22, 2026, for the supply of Ondansetron ODT 8 mg tablets in a 30-count package, with a ceiling value of $9,767.95. This is a firm fixed-price delivery order with an ultimate completion date of January 23, 2026, and represents a non-set-aside, competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen...
- The Defense Logistics Agency awarded a $6,754.83 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on December 2, 2025, with completion expected by December 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used to...